The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma

Published:2022-12-24 Issue:5 Volume:280 Page:2471-2478
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Guven Deniz Can,Erul Enes^ORCID,Yilmaz Feride,Yasar Serkan,Yildirim Hasan Cagri,Ercan Fatih,Kaygusuz Yunus,Cayiroz Kerim,Ucdal Mete Tugcan,Yesil Furkan,Yazici Gozde,Cengiz Mustafa,Gullu Ibrahim,Aksoy Sercan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

https://link.springer.com/content/pdf/10.1007/s00405-022-07804-x.pdf

Reference45 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

2. Aupérin A (2020) Epidemiology of head and neck cancers: an update. Curr Opin Oncol 32(3):178–186

3. Mesia R, Iglesias L, Lambea J et al (2021) SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clin Transl Oncol 23(5):913–921. https://doi.org/10.1007/s12094-020-02533-1

4. Machiels JP, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V (2020) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1462–1475. https://doi.org/10.1016/j.annonc.2020.07.011

5. Xiang M, Colevas AD, Holsinger FC, Le QX, Beadle BM (2019) Survival after definitive chemoradiotherapy with concurrent cisplatin or carboplatin for head and neck cancer. J Natl Compr Canc Netw 17(9):1065–1073. https://doi.org/10.6004/jnccn.2019.7297

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic immune-inflammation and prognostic immune nutritional index in oral squamous cell carcinoma patients;Biomarkers in Medicine;2024-09-13

2. Novel pretreatment nomograms based on pan-immune-inflammation value for predicting clinical outcome in patients with head and neck squamous cell carcinoma;Frontiers in Oncology;2024-06-10

3. Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?;Cardiovascular Toxicology;2024-04-15

4. Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal carcinoma;Cancer Medicine;2024-03-29

5. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma;Acta Otorrinolaringologica (English Edition);2024-03